Live tape
Top 8, mentions 7d16,942GOOGL3,786 mentions▲ +0.04SPCX2,546 mentions▲ +0.06MSFT2,182 mentions▲ +0.06TSLA1,967 mentions▲ +0.05NVDA1,651 mentions▲ +0.07META1,641 mentions▲ +0.03AAPL1,609 mentions▲ +0.07SNDK1,560 mentions▲ +0.05
Equity · Healthcare

CCCC

C4 Therapeutics, Inc. · NasdaqGS
$3.54
−1.39% 1D
Finazon · prior-day close · Jul 28, 2026

Reddit mentioned CCCC 2 times in the 30 days to 9 July 2026, in 1 of the communities we track. All of them were scored for sentiment: 100% read bullish, 0% bearish and 0% neither. Reddit data updated 9 July 2026.

Price · Chart Chart by TradingView
Track this symbol on TradingView
Market cap $391.4M
52-week range $1.70 – $4.66
Avg volume 726.8K
Mentions · 30d 2
Net sentiment +0.45
Bull share 100%

Finazon · prior-day close · valuation computed from SEC EDGAR filings · as of Jul 29, 2026

CCCC · crowd attention × price

Share ↗ 2 mentions
Bar chart of daily Reddit mentions for CCCC over the last 30 days; days with zero mentions show no bar. A solid accent line overlays the daily closing price in its own scale band. A dashed lead-in marks the untracked days before tracking began.$3.54130 Jun7 Jul14 Jul21 Jul29 Jul

The chart plots daily Reddit mentions of CCCC over the 30 days to 9 July 2026: 2 in total, busiest on 5 July with 1, and 1 on the last day counted. This window holds no data before 5 July 2026; the dashed lead-in marks that gap, which is not a run of zeroes. The line is the daily close over the same window: $4.66 on 30 June, $3.54 on 28 July.

Finazon · prior-day close

Crowd sentiment on CCCC · 30d

Method · 2 mentions
+0.45
Bullish
Bullish 100%
Neutral 0%
Bearish 0%

Across 2 classified mentions in the last 30 days, crowd sentiment for CCCC leans bullish, with 100% reading bullish against 0% bearish across the classified sample.

Where CCCC is discussed

Share of tracked-subreddit mentions · 30d
r/wallstreetbets 100% 2 mentions +0.45

CCCC insider trades

SEC Form 4
Date Insider Type Shares Value

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

10 Jul 2026 REYNO LEONARD Chief Medical Officer Option exercise 15,325
10 Jul 2026 REYNO LEONARD Chief Medical Officer Tax withheld 7,397 $30K
01 Jul 2026 Anderson Kenneth Carl Director Award 2,650 $12K
01 Jul 2026 GROGAN DONNA ROY Director Award 3,341 $14K
01 Jun 2026 Anderson Kenneth Carl Director Option exercise 1,070 $2K
01 Apr 2026 Anderson Kenneth Carl Director Award 4,259 $11K
01 Apr 2026 GROGAN DONNA ROY Director Award 5,370 $14K
15 Feb 2026 Hirsch Andrew President & CEO Option exercise 20,400

CCCC earnings

SEC EDGAR
Date Period EPS Revenue
31 Mar 2026 Q1 2026 $-0.20 $6M
31 Dec 2025 FY 2025 $-1.27 $36M
30 Sep 2025 Q3 2025 $-0.44 $11M
30 Jun 2025 Q2 2025 $-0.37 $6M

Reported figures & scheduled dates · SEC EDGAR filings

CCCC reported financials

SEC EDGAR XBRL

CCCC reported revenue of $35.9M for the fiscal year ended 31 Dec 2025. Net income over the same period was −$105.0M.

Figure Reported Period
Revenue $35.9M 31 Dec 2025 fiscal year
Net income −$105.0M 31 Dec 2025 fiscal year
Diluted EPS −$1.27 31 Dec 2025 fiscal year
Total assets $328.9M 31 Mar 2026 at period end
Total equity $234.2M 31 Mar 2026 at period end

Source: SEC EDGAR XBRL company facts · latest period ended 31 Mar 2026

CCCC institutional holders

SEC Form 13F

8 of the 45 institutional funds we track reported a CCCC position for the quarter ended 31 Mar 2026 — a combined $29.0M; the latest of those filings landed 15 May 2026.

Fund Action Shares Value
Two Sigma Investments Added +101.1% shares 3,035,634 $8.0M
Citadel Advisors Added +460.7% shares 2,511,015 $6.6M
Renaissance Technologies Added +53.6% shares 2,461,815 $6.5M
Millennium Management Held (±25%) +17.2% shares 1,393,342 $3.7M
D. E. Shaw & Co. Added +1,905.2% shares 1,060,331 $2.8M
Man Group Added +64.3% shares 256,468 $675K
Point72 Asset Management Trimmed −98.2% shares 169,096 $445K
Marshall Wace Trimmed −41.3% shares 155,495 $409K

Source: SEC EDGAR 13F filings

CCCC fails-to-deliver

SEC CNS data

On 29 Jun 2026, 54 shares of CCCC failed to deliver (about $230).

Settlement date Shares failed Notional % of shares out
29 Jun 2026 54 $230 <0.001%
18 Jun 2026 8,176 $32K 0.007%
15 Jun 2026 14 $55 <0.001%

Source: SEC fails-to-deliver (CNS) data

The Distributed Sentinel Daily Brief · 29 Jul 2026

The crowd leans clearly bullish on CCCC

The Distributed Sentinel reads 2 mentions for CCCC over the last 30 days against a net sentiment of +0.45. The split runs 100% bullish, 0% neutral and 0% bearish across the classified base — a reading to weigh against price and insider flow, not to trade on alone.

CCCC — frequently asked questions

From live data

Is Reddit bullish or bearish on CCCC?

Across 2 classified CCCC mentions in the last 30 days, 100% read bullish, 0% bearish and 0% neutral. Crowd sentiment is a social signal, not investment advice.

When did CCCC last report earnings?

C4 Therapeutics (CCCC) last reported earnings on 31 Mar 2026 for Q1 2026, per SEC filings.

Are CCCC insiders buying or selling?

SEC Form 4 filings over the last 90 days show 0 buys and 0 sells by CCCC insiders on the open market. A further 5 filings were grants, awards, gifts or exercises rather than open-market trades.

What exchange is CCCC listed on?

C4 Therapeutics trades on NASDAQ under the ticker CCCC.

Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.